Yang SF - Search Results

1

Genetic variants of ADAM9 as potential predictors for biochemical recurrence in prostate cancer patients after receiving a radical prostatectomy.

Lin YW, Wen YC, Lin CY, Hsiao CH, Ho KH, Huang HC, Chang LC, Wang SS, Yang SF, Chien MH. Lin YW, et al. Among authors: yang sf. Int J Med Sci. 2024 Nov 4;21(15):2934-2942. doi: 10.7150/ijms.103179. eCollection 2024. Int J Med Sci. 2024. PMID: 39628685 Free PMC article.

2

Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma.

Chang CC, Chen SC, Hsieh YH, Chen YC, Chen TY, Chu YH, Ma HJ, Chou MC, Tsai HT, Yang SF. Chang CC, et al. Among authors: yang sf. Clin Chem Lab Med. 2009;47(4):412-8. doi: 10.1515/CCLM.2009.092. Clin Chem Lab Med. 2009. PMID: 19327121

3

Genetic polymorphism of the tissue inhibitor of metalloproteinase-1 is associated with an increased risk of endometrial cancer.

Yi YC, Chen MK, Chen LY, Ho ES, Ying TH, Wang PH, Yang SF. Yi YC, et al. Among authors: yang sf. Clin Chim Acta. 2009 Nov;409(1-2):127-31. doi: 10.1016/j.cca.2009.09.015. Epub 2009 Sep 13. Clin Chim Acta. 2009. PMID: 19758569

4

Effect of CC chemokine ligand 5 and CC chemokine receptor 5 genes polymorphisms on the risk and clinicopathological development of oral cancer.

Weng CJ, Chien MH, Lin CW, Chung TT, Zavras AI, Tsai CM, Chen MK, Yang SF. Weng CJ, et al. Among authors: yang sf. Oral Oncol. 2010 Oct;46(10):767-72. doi: 10.1016/j.oraloncology.2010.07.011. Epub 2010 Aug 21. Oral Oncol. 2010. PMID: 20729133

5

Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma.

Chien MH, Yeh KT, Li YC, Hsieh YH, Lin CH, Weng MS, Kuo WH, Yang SF. Chien MH, et al. Among authors: yang sf. J Surg Oncol. 2011 Sep 1;104(3):299-304. doi: 10.1002/jso.21929. Epub 2011 Apr 1. J Surg Oncol. 2011. PMID: 21462191 Clinical Trial.

6

Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathologic development of oral cancer.

Chien MH, Chou LS, Chung TT, Lin CH, Chou MY, Weng MS, Yang SF, Chen MK. Chien MH, et al. Among authors: yang sf. Head Neck. 2012 Mar;34(3):405-11. doi: 10.1002/hed.21746. Epub 2011 Apr 5. Head Neck. 2012. PMID: 21472888

7

Terbinafine inhibits oral squamous cell carcinoma growth through anti-cancer cell proliferation and anti-angiogenesis.

Chien MH, Lee TS, Kao C, Yang SF, Lee WS. Chien MH, et al. Among authors: yang sf. Mol Carcinog. 2012 May;51(5):389-99. doi: 10.1002/mc.20800. Epub 2011 May 11. Mol Carcinog. 2012. PMID: 21563217

8

Interleukin-23 receptor polymorphism as a risk factor for oral cancer susceptibility.

Chien MH, Hsin CH, Chou LS, Chung TT, Lin CH, Weng MS, Chou MY, Chen MK, Yang SF. Chien MH, et al. Among authors: yang sf. Head Neck. 2012 Apr;34(4):551-6. doi: 10.1002/hed.21779. Epub 2011 Jun 29. Head Neck. 2012. PMID: 21717520

9

Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.

Su CK, Yeh KT, Yeh CB, Wang PH, Ho ES, Chou MC, Liu KC, Yang SF, Yi YC. Su CK, et al. Among authors: yang sf. J Surg Oncol. 2011 Dec;104(7):755-9. doi: 10.1002/jso.22035. Epub 2011 Jul 14. J Surg Oncol. 2011. PMID: 21761413

10

Relationship of interleukin-8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development.

Chien MH, Yeh CB, Li YC, Wei LH, Chang JH, Peng YT, Yang SF, Kuo WH. Chien MH, et al. Among authors: yang sf. J Surg Oncol. 2011 Dec;104(7):798-803. doi: 10.1002/jso.22037. Epub 2011 Jul 20. J Surg Oncol. 2011. PMID: 21780129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,467 results

Search Page

Filters